Diane Powis Ovarian Cancer Testing Access Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 3, 2022
Referred to the Subcommittee on Health.
Sep 30, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 30, 2022
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Diane Powis Ovarian Cancer Testing Access Act
This bill provides for Medicare coverage of multimarker tests related to ovarian cancer (i.e., tests that evaluate more than one tumor marker with respect to ovarian cancer).
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cite this page
U.S. Congress. (2026). H.R. 9090: Diane Powis Ovarian Cancer Testing Access Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-9090/
"H.R. 9090: Diane Powis Ovarian Cancer Testing Access Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-9090/.
H.R. 9090, 117th Cong. (2026), https://openamerica.io/bill/117-HR-9090/.
[H.R. 9090: Diane Powis Ovarian Cancer Testing Access Act](https://openamerica.io/bill/117-HR-9090/)